1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA EPHA2 CTRPv2 pan-cancer AAC -0.16 5e-05
mRNA CARD10 CTRPv2 pan-cancer AAC -0.16 0.0001
mRNA RHOG CTRPv2 pan-cancer AAC -0.16 5e-05
mRNA MAPKAPK3 CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA KIF13A CTRPv2 pan-cancer AAC -0.16 5e-05
mRNA FAM212A CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA OPHN1 CTRPv2 pan-cancer AAC -0.16 4e-05
mRNA TSPAN4 CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA FHL2 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA TNFRSF1A CTRPv2 pan-cancer AAC -0.15 2e-05
Download CSV